Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05598801 · ClinicalTrials.gov registry record
A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand
A clinical trial of Tendon Repair and Fracture Repair, sponsored by Research Source.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT05598801: Completed study of Tendon Repair and Fracture Repair, sponsored by Research Source.
NCT05598801 is a study of Tendon Repair and Fracture Repair that has completed, run by Research Source. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05598801, a study of Tendon Repair and Fracture Repair, has completed, sponsored by Research Source.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy on the use of VersaWrap® in surgery of the hand/fingers, including tendon repair, fracture repair, or tenolysis of the hand/fingers. VersaWrap is designed to allow tendon gliding and to protect tendon gliding postoperatively
Conditions Studied
Interventions
- DEVICE VersaWrap
Study Locations (1)
Texas
- Austin Hand Group - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2025-08-17 |
What the finished NCT05598801 record still lists
NCT05598801 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 3 conditions, with Tendon Repair appearing as the primary indexed condition, and to 1 intervention - of which VersaWrap is the first listed.
NCT05598801 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05598801 about?
NCT05598801 is a clinical study titled "A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand". The purpose of this study is to evaluate the efficacy on the use of VersaWrap® in surgery of the hand/fingers, including tendon repair, fracture repair, or tenolysis of the hand/fingers. VersaWrap is designed to allow tendon gliding and to protect tendon gliding postoperatively
What is the current status of trial NCT05598801?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2022-09-01. Estimated completion is 2025-08-17.
What conditions does trial NCT05598801 study?
This clinical trial studies the following conditions: Tendon Repair, Fracture Repair, Tenolysis.
What interventions are being tested in trial NCT05598801?
The interventions under investigation include: VersaWrap (DEVICE).
Who is sponsoring clinical trial NCT05598801?
This trial is sponsored by Research Source, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05598801 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI